JOURNAL ARTICLE

The Supreme Court upholds access to mifepristone in a unanimous decision on abortion.

  • Published In: Fortune.com, 2024. P. N.PAG 1 of 3

  • Database: Business Source Ultimate 2 of 3

  • Authored By: Hinchliffe, Emma; Abrams, Joseph 3 of 3

Abstract

The article focuses on a unanimous Supreme Court decision regarding the regulation of the abortion pill mifepristone, affirming the FDA's authority and rejecting a lawsuit that challenged its approval. Justice Brett Kavanaugh, who previously supported the overturning of Roe v. Wade, emphasized that the plaintiffs lacked standing to sue without demonstrating personal injury from the government's actions. The ruling is seen as a relief for the pharmaceutical industry, which feared broader implications for drug approvals. However, advocates for reproductive rights, like Melinda French Gates, caution that the fight for women's autonomy continues amid ongoing legal challenges. [Extracted from the article]

Additional Information

  • Source:Fortune.com. 2024/06, pN.PAG
  • Document Type:Article
  • Subject Area:Law
  • Publication Date:2024
  • Accession Number:177904870
  • Copyright Statement:Copyright of Fortune.com is the property of Fortune Media (USA) Corporation and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.